0.882
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire
Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat
Stephens Inc. AR Makes New $303,000 Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix CFO sells $22,794 in stock - MSN
Biodesix CEO Scott Hutton sells shares worth $77,318 - MSN
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Biodesix Inc Stock: Insider Sales Spark Market Concerns - sharewise
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock By Investing.com - Investing.com Australia
Biodesix CEO Scott Hutton sells shares worth $77,318 By Investing.com - Investing.com Australia
Biodesix chief commercial officer sells shares worth $16,198 By Investing.com - Investing.com Australia
Biodesix CFO sells $22,794 in stock By Investing.com - Investing.com Australia
BIODESIX Executives Sell Shares to Cover Taxes - TradingView
Biodesix Inc [BDSX] Shares Rise 5.00 % on Wednesday - Knox Daily
Market Watch: Biodesix Inc (BDSX)’s Noteworthy Gain, Closing at 1.05 - The Dwinnex
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 7.4% - MarketBeat
Reviewing Biodesix (NASDAQ:BDSX) and Sera Prognostics (NASDAQ:SERA) - Defense World
Barclays PLC Acquires 21,179 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
BDSX stock touches 52-week low at $1 amid market challenges - MSN
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Drops By 7.4% - MarketBeat
The Price Is Right For Biodesix, Inc. (NASDAQ:BDSX) Even After Diving 27% - Simply Wall St
BDSX stock touches 52-week low at $1.11 amid market challenges - Investing.com
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Barclays PLC - Defense World
Preliminary results show sales boost for Biodesix - BizWest
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewswire
Biodesix Achieves Record 45% Revenue Growth to $71.3M as Lung Diagnostics Surges in 2024 - StockTitan
Geode Capital Management LLC Has $1.43 Million Stock Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - The Manila Times
Biodesix's Lung Cancer Blood Test Outperforms PET Scans in Major Clinical Study - StockTitan
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 44.7% - MarketBeat
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Wilmington Savings Fund Society FSB Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):